RIL
IOVA icon

Rothschild Investment LLC’s Iovance Biotherapeutics IOVA Stock Holding History

Rothschild Investment LLC’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.77K Buy
789
+443
+128% +$1.42K ﹤0.01% 2388
2025
Q4 		$945 Sell
346
-4
-1% -$9 ﹤0.01% 2699
2025
Q3 		$760 Buy
350
+130
+59% +$307 ﹤0.01% 2698
2025
Q2 		$378 Sell
220
-10
-4% -$25 ﹤0.01% 2822
2025
Q1 		$766 Sell
230
-10
-4% -$52 ﹤0.01% 2479
2024
Q4 		$1.78K Sell
240
-30
-11% -$278 ﹤0.01% 1879
2024
Q3 		$2.54K Buy
270
+210
+350% +$1.99K ﹤0.01% 1603
2024
Q2 		$481 Buy
60
+40
+200% +$429 ﹤0.01% 2043
2024
Q1 		$296 Buy
+20
New +$233 ﹤0.01% 1563

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return